Short title: Real-world Omalizumab and Mepolizumab
outcomes
Authors: Wei Chern Gavin Fong*1,2 , Adnan
Azim*2,3, Deborah Knight3, Heena
Mistry1,2,3, Anna Freeman2,3, Mae
Felongco2,3, Aref Kyyaly1,2,3,
Matthew Harvey2,3, Patrick
Dennison3, Hongmei Zhang4, Peter
Howarth2,3 S Hasan Arshad1,2,3 and
Ramesh J Kurukulaaratchy1,2,3
Affiliations: 1David Hide Asthma and Allergy
Research Centre, Isle of Wight, UK. 2Clinical and
Experimental Sciences, Faculty of Medicine, University of Southampton,
Southampton, UK. 3 NIHR Southampton Biomedical
Research Centre, University Hospitals Southampton NHS Foundation Trust,
Southampton. 4Division of Epidemiology, Biostatistics,
and Environmental Health, School of Public Health, University of
Memphis, Memphis, TN, USA.
*contributed equally